Home › Multiple Myeloma › Wisconsin › La Crosse
Multiple Myeloma clinical trials in La Crosse, WI
4 studies for Multiple Myeloma are looking for participants at sites in and around La Crosse (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
Recruiting
- Mayo Clinic Health System-Franciscan Healthcare, La Crosse
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RecruitingPhase 3
- Gundersen Lutheran Medical Center, La Crosse
Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
RecruitingPhase 3
- Gundersen Lutheran, La Crosse
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RecruitingPhase 3
- Gundersen Lutheran Medical Center, La Crosse
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Chicago, IL22 studies
Other studies in La Crosse
- Non-Small Cell Lung Cancer10 studies
- Lung Cancer9 studies
- Acute Myeloid Leukemia6 studies
- Breast Cancer6 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Laryngeal Cancer3 studies
- Oral Cancer3 studies
- Melanoma3 studies
- Endometrial Cancer3 studies
- Ovarian Cancer3 studies
- Diffuse Large B-Cell Lymphoma3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.